TidalHealth’s Mobile Integrated Health/SWIFT team made history in December by administering the first home-based monoclonal antibody infusion in Maryland to Steven Webster of Mardela Springs.
The ability to administer the Covid-19 treatment in a patient’s home is not only historic, it also reduces emergency department utilization at a time when volumes are unprecedented, and it opens the door to access for people who have multiple barriers to receiving care. Monoclonal antibody infusion is used to reduce the severity of Covid-19 effects in patients who are early in their exposure.
These treatments have historically been administered in a hospital setting, including the Robert T. Adkins Emergency/Trauma Center at TidalHealth Peninsula Regional.
“TidalHealth is committed to supporting the health of our friends, families and neighbors. The SWIFT team is an innovative program that reduces unnecessary strain on emergency services and the emergency department while connecting patients to the right care, at the right time, in the right place,” said Katherine Rodgers, Director of TidalHealth Community Health Initiatives. “We are constantly trying to evolve the program and the services the SWIFT team can provide in their patients’ homes. Bringing the monoclonal antibody infusion directly to a patient served by the SWIFT team is a perfect example of how the team and TidalHealth breaks down barriers to improve efficiency and health care.”
The team, led by Nurse Practitioner Dr. Aaron Sebach, coordinated with the TidalHealth Pharmacy and Emergency Department to acquire the requisite infusion supplies. While Salisbury Fire Department Paramedic Kara Harrington inserted an IV, Nurse Practitioners Dr. Aaron Sebach and Tammy Walbert obtained consent and set up the infusion.
The infusion was a success, and Webster said he appreciated the ability to receive care in his home.